JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, vol.104, no.7, pp.2527-2534, 2019 (SCI-Expanded)
Context: Dopamine agonist (DA)-induced impulse control disorder (ICD) in patients with prolactinomas is not sufficiently known.